Brown Michael Jon sold 1,700 shares of DEXCOM INC at $83.46 for −$142k on Nov 16, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
EVP Chief Legal Compliance Off
EVP Chief Legal Compliance Off
Filed Nov 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$141,882Shares × reported price
Shares traded
1,700Common Stock
Price per share
$83.46Reported price. Read footnotes for ranges.
% of reported position traded
1.76%This security and ownership context
Holdings after
95,034Direct
Trade date
Nov 16, 2026Sell
Filed
Nov 18, 2026, 4:04 PM ET2-day reporting delay
Accession
0001093557-26-000209Code S · Transaction 405616
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 96,734 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

DXCM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
DXCM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +4.9%1w ago −1.2%1d ago +1.6%
Returns since7d30d90d180d1y

Footnotes in full

F1: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2: Included in this number are 69,053 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 2,849 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027.